Editas Medicine, Inc.
Biological Products, (No Diagnostic Substances) · 11 HURLEY ST., CAMBRIDGE, MA 02141
官方登記資料
0位追蹤者
2013成立於
關於 Editas Medicine, Inc.
Editas Medicine, Inc.,, is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.
Source: Wikipedia
產業Biological Products, (No Diagnostic Substances)
總部11 HURLEY ST., CAMBRIDGE, MA 02141
成立時間2013
法律形式C Corporation
狀態營運中
專利593 項專利
CRISPR-RELATED METHODS AND COMPOSITIONS TARGETING FL1-1 EXPRESSIONUS20260241033A1 · 2026
CRISPR-RELATED METHODS AND COMPOSITIONS TARGETING LOW-DENSITY LIPOPROTEIN RECEPTOR (LDLR)US20260242779A1 · 2026
關鍵數據
法律資訊
| 法定名稱 | Editas Medicine, Inc. |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1650664在 SEC EDGAR 上查看 ↗ |
| EIN | 46-4097528 |
| 產業代碼(SIC) | 2836 |
| 登記地址 | 11 HURLEY ST., CAMBRIDGE, MA 02141 |
| 狀態 | 營運中 |
來源: SEC EDGAR · 更新於 2026年10月15日